Axillary lymph node dissection in non-palpable breast cancers;Le curage ganglionnaire axillaire dans les cancers infracliniques du sein

Bulletin du Cancer

Volumn 83, Issue 7, 1996, Pages 581-588

  Le Bouedec G ^a   Pomel, C ^a   Chamussy, E ^a   Feillel, V ^a   De Latour, M ^a   Dauplat, J ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

axillary dissection; lymph node status; non palpable breast cancer

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CARCINOMA IN SITU; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MUCINOUS CARCINOMA; TUMOR VOLUME;

AGED; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, STEROID; RETROSPECTIVE STUDIES;

EID: 0029793615     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ahlgren J, Stal O, Westman G, Arnesson LG. Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncol 1994;33:603-8
2. Amalric R, Brandone H, Ayme Y et al. Le traitement conservateur des cancers du sein infracliniques (T0 N0). À propos de 231 canalaires infiltrants. Bull Cancer 1993; 80:234-40
3. Arnesson LG, Smeds S, Fagerberg G. Recurrence-free survival in patients with small breast cancers. An analysis of cancers 10 mm or less detected clinically and by screening. Eur J Surg 1994;160:271-6
4. Avigdor S, Lebas P, de Rouchet E, Lansac J, Body G. Lésions mammaires infracliniques révélées par des microcalcifications. Corrélations historadiologiques. À propos d'une série rétrospective de 127 cas. J Gynecol Obstet Biol Reprod 1994;23:365-72
5. e Congrès Français de Chirurgie, Nice, septembre 1995:55-7
6. Bauer TL, Pandelidis SM, Rhoads JE, Jr. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy. J Am Coll Surg 1994;178:427-30
7. Bobin JY, Delay E, Rivoire M. Le traitement des cancers ductaux in situ du sein. Bull Cancer/Radiother 1993;80: 493-7
8. Cabannes PA, Salmon RJ, Vilcoq JR et al. Value of axillary dissection in addition to lympectomy and radiotherapy in early breast cancer. The breast carcinoma collaborative group of the Institut Curie. Lancet 1992;339:1245-8
9. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-8
10. Charpin C, Andrac L, Habib MC, Vacheret H, Lavaut MN, Piana L. Les cancers du sein impalpables. Étude histologique et immunohistochimique. Arch Anat Cytol Pathol 1994;42:225-33
11. Ciatto S, Rosselli Del Turco M, Bonardi R et al. Non-palpable lesions of the breast detected by mammography. Review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994;30A:40-4
12. Contesso G. Cancers impalpables du sein. Le point de vue du pathologiste. Arch Anat Cytol Pathol 1995;43:117-8
13. Cutuli BF, Rodier JF, Jaeck D. Traitement conservateur radiochirurgical dans le cancer canalaire in situ du sein. Analyse de 86 observations. Presse Méd 1994;23:1153-7
14. Dauplat J, Le Bouëdec G, Travade A et al. Technique chirurgicale pour l'exérèse des anomalies radiologiques infracliniques du sein. J Chir 1987;124:475-82
15. Dilhuydy MH, Goibert JL, Trojani M, Raymond AJ, Bonichon F, Le Treut A. La demande de la biopsie chirurgicale en mammographie. À propos de 140 cas vérifiés. Rev Fr Gynecol Obstet 1985;80:599-604
16. Dowlatshahi K, Snider H, Kim R. Axillary node status in nonpalpable breast cancer. Ann Surg Oncol 1995;2:424-8
17. Fentiman IS, Fagg N, Millis RR, Hayward JL. In situ ductal carcinoma of the breast: implication of disease pattern and treatment. Eur J Surg Oncol 1986;12:261-6
18. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM, and Collaborating NSABP Investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986;57: 197-208
19. Gump FE, Jicha DL, Ozello L. Ductal carcinoma in situ (DCIS): a revised concept. Surgery 1987;102:790-5
20. Halverson KJ, Taylor ME, Perez CA et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994;17:461-6
21. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21
22. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, De Palo AH, Rosen PP. Breast carcinoma in situ. Arch Surg 1989; 124:33-6
23. Kopald HK, Hiatt JR, Irving Ch, Giuliano AE. The pathology of non palpable breast cancer. Am J Surg 1990;56: 782-7
24. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63:618-4
25. Le Bouëdec G, Kauffmann P, Pingeon JM, Pomel C, Dauplat J. Cancers infracliniques invasifs du sein. A propos de 136 cas. Ann Chir 1994;48:607-12
26. Liebens F. Place de l'évidement axillaire et nouvel aspect technique dans le traitement chirurgical du cancer du sein. Rev Méd Brux 1995;16:227-30
27. Lin PP, Allison DC, Wainstock J et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44
28. Margolis DS, McMillen MA, Hashmi H, Wasson DW, McArthur JD. Aggressive axillary evaluation and adjuvant therapy for non palpable carcinoma of the breast. Surg Gynecol Obstet 1992;174:109-13
29. Marrujo G, Jolly PC, Hall MH. Non palpable breast cancer: needle-localized biopsy for diagnosis and considerations for treatment. Am J Surg 1986;151:599-602
30. Meynard P, Jacquemier J, Hans D et al. Carcinomes mammaires impalpables : analyse morphologique et histogenèse. À propos de 114 cas. Bull Cancer 1989;76:653-63
31. Papatestas AE, Hermann D, Tsevdos T, Lesnick G. Surgery for non palpable breast lesions. Arch Surg 1990;125: 399-402
32. Perdue Ph, Page D, Nellestein M, Salem C, Galbo C, Ghosh B. Early detection of breast carcinoma: a comparison of palpable and non palpable lesions. Surgery 1992; 111:656-9
33. Radford DM, Cromack DT, Troop BR, Keller SM, Lopez MJ. Pathology and treatment of impalpable breast lesions. Am J Surg 1992;164:427-32
34. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer. Cancer 1995;76:1491-1512
35. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;157:501-2
36. Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion: a curable entity using surgery alone without need for adjuvant therapy. Cancer 1991;67: 1498-1503
37. Saccomandi E, Clough KB, Mosseri V et al. Cancers du sein révélés par des microcalcifications sans tumeur palpable. Pronostic et traitement. Presse Méd 1995;24: 1291-5
38. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986;121: 1303-7
39. Schwartz GF, Carter DL, Conant EF, Gannon FH, Finkel GC, Feig SA. Mammographically detected breast cancer. Non palpable is not a synonym for inconsequential. Cancer 1994;73:1660-5
40. Silverstein MJ, Waisman JR, Colburn WJ et al. Intraductal breast carcinoma (DCIS) with and without microinvasion (MI): is there a difference in outcome? Proc Am Soc Clin Oncol 1993;12:24
41. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1A breast carcinoma. Is it indicated? Cancer 1994; 73:664-7
42. Solin LJ, Fowble BL, Yeh IT et al. Microinvasive ductal carcinoma of the breast treated with breast conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1992;23:961-8
43. Symmonds RE, Roberts JW. Management of non palpable breast abnormalities. Ann Surg 1987;205:520-4
44. Tinnemans JGM, Wobbes T, Holland R, Hendriks JHC, van der Sluis RF, De Boer HH. Treatment and survival of female patients with non palpable breast carcinoma. Ann Surg 1989;209:249-53
45. von Reuden DG, Wilson RE. Intraductal carcinoma of the breast. Surg Gynecol Obstet 1984;158:105-11
46. von Rosen A, Frisell J, Glas V et al. Non palpable invasive breast carcinomas from the Stockholm screening project. Acta Oncologica 1989;28:23-7
47. Walls J, Boggis CRM, Wilson M et al. Treatment of the axilla in patients with screen-detected breast cancer. Br J Surg 1993;80:436-8
48. Wong JH, Kopald KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990;125: 1298-1302
49. Wood WC. Should axillary dissection be performed in patients with DCIS? Ann Surg Oncol 1995;2: 193-4
50. Zafrani B. Les carcinomes intracanalaires du sein: aspects anatomopathologiques. Bull Cancer/Radiother 1993;80: 489-91